WITHUS PHARMACEUTICAL Co.,LTD. (KOSDAQ:330350)
South Korea flag South Korea · Delayed Price · Currency is KRW
8,580.00
-320.00 (-3.60%)
At close: Feb 13, 2026

KOSDAQ:330350 Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
19,33417,8939,1739,01213,83115,490
Short-Term Investments
1,0001,0001,00010,5002,5003,500
Trading Asset Securities
1,046-1,0197,04426,14720,444
Cash & Short-Term Investments
21,38018,89311,19226,55642,47839,435
Cash Growth
80.52%68.81%-57.85%-37.48%7.72%-11.73%
Accounts Receivable
26,16322,10525,79717,83518,63520,408
Other Receivables
529.8544.94292.4377.4278.4581.57
Receivables
30,49726,09930,97823,37224,22826,625
Inventory
17,94316,15116,0049,0218,1417,922
Prepaid Expenses
52.1924.0143.49317.71,52326.92
Other Current Assets
30.885.2129.52183.7958.66.28
Total Current Assets
69,90361,17358,24759,45176,42774,015
Property, Plant & Equipment
47,83949,23649,94539,84325,37920,071
Long-Term Investments
10,40411,88112,0999,6378,7337,209
Other Intangible Assets
4,5484,5732,5322,5281,5481,542
Long-Term Accounts Receivable
-0-0-00-00
Long-Term Deferred Tax Assets
1,4391,4711,1981,5491,3801,459
Long-Term Deferred Charges
6,6976,2666,3155,8935,0351,408
Other Long-Term Assets
89.8887.95443.21493.87476.13475.93
Total Assets
140,920134,687130,780119,395118,979106,180
Accounts Payable
4,5873,6207,1903,4472,4352,869
Accrued Expenses
1,2461,1911,0661,0371,1541,085
Short-Term Debt
19,00019,00011,42412,51912,83910,589
Current Portion of Long-Term Debt
2,3332,3333,3332,0001,0001,900
Current Portion of Leases
151.63172.04201.49172.31280.27303.09
Current Income Taxes Payable
872.06298.63243.82645.94761.3128.5
Other Current Liabilities
8,1267,3237,5525,7525,5063,475
Total Current Liabilities
36,31633,93831,01125,57223,97520,349
Long-Term Debt
583.322,3334,6676,6008,7004,000
Long-Term Leases
179.3226.39375.14175.65285.61426.53
Pension & Post-Retirement Benefits
5,6185,0734,4494,0115,1134,527
Other Long-Term Liabilities
-0000-0
Total Liabilities
42,69641,57140,50236,35938,07429,303
Common Stock
2,6402,6402,6402,6392,6381,758
Additional Paid-In Capital
15,10915,10915,10914,99714,94815,846
Retained Earnings
79,84074,73371,89464,73662,64258,880
Treasury Stock
-35.66-35.66-35.66-35.66-35.66-
Comprehensive Income & Other
670.63670.63670.63700.16713.26393.34
Shareholders' Equity
98,22493,11790,27883,03680,90576,877
Total Liabilities & Equity
140,920134,687130,780119,395118,979106,180
Total Debt
22,24824,06520,00121,46723,10517,219
Net Cash (Debt)
-867.62-5,172-8,8095,08919,37322,216
Net Cash Growth
----73.73%-12.80%-23.81%
Net Cash Per Share
-65.64-391.79-667.36385.931467.592685.10
Filing Date Shares Outstanding
13.213.213.213.1913.1913.19
Total Common Shares Outstanding
13.213.213.213.1913.1913.19
Working Capital
33,58727,23527,23633,87852,45253,666
Book Value Per Share
7441.387054.466839.416295.236135.625829.05
Tangible Book Value
93,67688,54487,74680,50879,35775,335
Tangible Book Value Per Share
7096.826708.036647.626103.586018.205712.10
Land
6,9856,9856,9856,5966,2386,238
Buildings
30,54334,89634,89610,0579,6579,657
Machinery
9,69721,82118,05014,25013,51912,346
Construction In Progress
290.579.41,97619,7515,838546
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.